ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Market News
Leading broker names 5 high conviction ASX shares to buy in August
Share Market News
Warning: The Australian dollar and gold price are now flashing red at GFC levels
Share Market News
Earnings season weekly review: Credit Corp, GUD, ResMed, & Rio Tinto
Share Gainers
Why Lynas, ResMed, Resolute, & Sydney Airport shares pushed higher today
Growth Shares
Where to invest $20,000 in ASX 200 shares next month
Share Market News
Top brokers name 3 ASX shares to buy today
Growth Shares
The Cochlear share price just hit an all-time high: Too late to invest?
Share Market News
Goldman Sachs rates ResMed shares a buy, claims still cheaper than Cochlear, CSL
Share Market News
Leading brokers name 3 ASX shares to buy today
Share Market News
Leading broker upgrades ResMed shares to a buy rating
Share Gainers
Why Woolworths and these ASX shares just raced to 52-week highs
Share Market News
4 investment stories you missed in the ASX200 this week
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
